3′-or 2′-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections

Patent Citations (56)

Non-Patent Literature (83)

• McGuigan et al., “Alkyl hydrogen phosphonate derivatives of the anti-HIV agent AZT may be less toxic than the parent nucleoside analogue”, Antiviral Chemistry and Chemotherapy, 1994, 5(4), 271-277.Examiner
• Fedorov, I., et al., XIII International Round Table: Nucleosides, Nucleotides and Their Biological Applications. Montpellier, France, Sep. 6-10, 1998. Poster 35.Applicant
• Kato, K., et al., XIII International Round Table: Nucleosides, Nucleotides and Their Biological Applications. Montpellier, France, Sep. 6-10, 1998. Poster 49.Applicant
• Svansson, L., et al., J. Org. Chem., 1991, 56: 2993-97.Applicant
• Wengel, J., et al., Bioorganic & Medicinal Chemistry, vol. 3, No. 9, pp. 1223-1229, 1995.Applicant
• Lin, T., et al., J. Med. Chem., 1993, 36:353-62.Applicant
• Gauvry, N., et al., Tetrahedron 55 (1999) 1321-28.Applicant
• Sterzyncki, R., et al., Nucleosides & Nucleotides, 10(1-3), 291-94 (1991).Applicant
• Lee-Ruff, E., et al., J. Med. Chem., 1996, 39:5276-80.Applicant
• Bamford, M., et al., J. Med. Chem., 1990, 33:2494-2501.Applicant
• Tino, J., J. Med. Chem, 1993, 36:1221-29.Applicant
• Brown, B., J. Org. Chem., 1998, 63:8012-18.Applicant
• Pudlo, J., Nucleosides & Nucleotides, 11(2-4), 279-93 (1992).Applicant
• Fiandor, J., et al., Nucleosides & Nucleotides, 8(5&6), 1107-8 (1989).Applicant
• Jeong, L., et al., Nucleosides & Nucleotides, 16(7-9), 1059-62 (1997).Applicant
• Jorgensen, P., et al., Nucleosides & Nucleotides, 16(7-9), 1063-66 (1997).Applicant
• Frieden, M., et al., J. Chem. Soc. Perkin Trans I, 1998, 2827-32.Applicant
• Slusarchyk, W., J. Med Chem., 1992, 35:1799-1806.Applicant
• Bisacchi, G., et al., J. Med. Chem., 1991, 34:1415-21.Applicant
• Qiu, Y., et al., J. Med. Chem., 1998, 41:10-23.Applicant
• Sekiyama, T., J. Med. Chem., 1998, 41:1284-98.Applicant
• Altmann, K.H., et al., “The Synthesis of 1′-methyl carbocyclic thymidine and its effect on nucleic acid duplex stability”, Synlett, Thieme Verlag, Stuttgart, De, Oct. 1994, 10, 853-855.Applicant
• Baginsky, S.G. et al., “Mechanism of action of a pestivirus antiviral compound,” Proc. Nat. Acad. Sci. (USA) 2000, 97(14), 7981-7986.Applicant
• Beigelman, L.N., et al, “Dimerization during the acetolysis of 3-O-acetyl-t-O-benzoyl-1,2-O-isopropylidene-3-C-methyl-α-D-ribofruanose. synethesis of 3′-C-methylnucleosides with the β-D-ribo-and α-D-arabino configurations”, Carbohydrate Research, 1988, 181, 77-88.Applicant
• Beigelman, L.N., et al, “A general method for synthesis of 3′-C-alkylnucleosides”, Nucleic Acids Symp. Ser., 1981, 9, 116-119.Applicant
• Berenguer et al, “Hepatitis B and C Viruses: Molecular Identification and Targeted Antiviral Therapies,” Proceedings of the Association of American Physicians, 1998, 110(2), 98-112.Applicant
• Carroll, S.S., et al. “Inhibition of Hepatitis C Virus RNA Replication by 2′-Modified Nucleoside Analogs,” The Journal of Biological Chemistry, 2003, 278(14), 11979-11984.Applicant
• Czernecki, S., et al, “Syntheses if Various 3′-Brached 2′,3′-Unsaturated Pyrimidine Nucleosides as Potential Anti-HIV Agents,” J. Org. Chem., 1992, 57, 7325-7328.Applicant
• DeFrancesco, R. et al., “Approaching a new era for hepatitis C virus therapy: inhibitors fot eh NS3-4A serine protease and the NS5B RNA-dependent RNA polymerase,” Antiviral Research, 2003, 58, 1-16.Applicant
• Faivre-Buet, V., et al, “Synthesis of 1′-Deoxypsicofuranosyl-deoxynucleosides as Potential Anti-HIV Agents,” Nucleosides & Nucleotides, 1992, 11(7), 1411-1424.Applicant
• Farkas, J., et al., “Nucleic acid components and their analogues. XCIV. Synthesis of 6-amino-9-(1-deoxy-□-D-psicofuranosyl)purine” Collect. Czech. Chem. Commun. 1967, 32, 2663-2667.Applicant
• Farkas, J., “Nucleic acids components and their analogues. LXXIX. Synthesis of methyl 1-deoxy-D-psicofuranosides substituted at C(1) with haolo atoms or a mercapto group,”, Collect. Czech. Chem. Commun. 1966, 31, 1535-1543.Applicant
• Federov, I.I., et al, “3′-C-branched 2′-deoxy-5-methyluridines: Synthesis, enzyme inhibition, and antiviral properties,”, J. Med. Chem., 1992, 35, 4567-4575.Applicant
• Franchetti, P., et al, “2′-C-methyl analogues of selective adenosine receptor agonists: Synthesis and binding studies,” J. Med. Chem., 1998, 41, 1708-1715.Applicant
• Grouiller, A., et al., “Novel p-tolyenesulfonylation and thionocarbonylation of unprotected thymine nucleosides,” Synlett, 1993, 221-222.Applicant
• Haraguchi, K., et al, “Preparation and reactions of 2′- and 3′- vinyl bromides of uracil-nucleosides: versatile synthons for anti-HIV agents,” Tetrahedron Letters, 1991, 32(28), 3391-3394.Applicant
• Haraguchi, K., et al, Stereoselective synthesis of 1′-C-branched uracil nucleosides from uridine, Nucleosides & Nucleotides, 1995, 14, 417-420.Applicant
• Harry-O'Kuru, et al., “A short, flexible route toward 2′-C-branched ribonucleosides”, J. Org. Chem. 1997, 62, 1754-1759.Applicant
• Harry-O'Kuru, R.E., et al., “2′-C-Alkylribonucleosides: Design, Synthesis, and Conformation,” Nucleosides & Nucleotides, 1997, 16(7-9), 1457-1460.Applicant
• Hattori, H., et al., “Nucleosides and Nucleotides. 175. Structural requirements of the suga moiety for the antitumor activities of new nucleoside antimetabolites, 1-(3-C-ethynyl-β-D-ribo-pentofuranosyl)cytosine and -uracil,” J. Med. Chem., 1998, 41, 2892-2902.Applicant
• Hrebabecky, H. et al., “Nucleic acid components and their analogues. CXLIX. Synthesis of pyrimidine nucleosides derived from 1-deoxy-D-psicose,” Collect. Czech. Chem. Commun. 1972, 37, 2059-2065.Applicant
• Hrebabecky, H., et al., “Synthesis of 7- and 9β-D-psicofuranosylguanine and their 1′-deoxy derivatives,” Collect. Czech. Chem. Commun. 1974, 39, 2115-2123.Applicant
• Iino, T., et a.l, “Nucleosides and Nucleotides. 139. Stereoselective synthesis of (2′S)-2′-C-alkyl-2′-deoxyuridines,” Nucleosides and Nucleotides, 1996, 15, 169-181.Applicant
• Itoh, Y., et al., “Divergent and stereocontrolled approach to the synthesis of uracil nucleosides branched at the anomeric position,” J. Org. Chem., 1995, 60, 656-662.Applicant
• Johnson, C.R., et al, 3′-C-trifuloromethyl ribonucleosides, Nucleosides & Nucleotides, 1995, 14, 185-194.Applicant
• Kawana, M., et al, “The deoxygenation of tosylated adenosine derivatives with Grignard reagents,” Nucleic Acids Symp. Ser., 1986, 17, 37-40.Applicant
• Lavaire, S., et al, “3′-deoxy-3′-trifluoromethyl nucleosides: synthesis and antiviral evaluation,” Nucleosides & Nucleotides, 1998, 17, 2267-2280.Applicant
• Leyssen, P. et al., “Perspectives for the treatment of infections with Flaviviridae”, Clinical Microbiology Reviews, Washington, D.C., (Jan. 2000), 13(1), 67-82.Applicant
• Martin, X., et al., “Intramolecular hydrogen bonding in primary hydroxyl of thymine 1-(1-deoxy-β-D-psicofuranosyl) nucleoside,” Tetrahedron, 1994, 50, 6689-6694.Applicant
• Matsuda, A., et al., “Radical deoxygenation of tert-alcohols in 2-branched-chain sugar pyrimidine nucleosides: synthesis and antileukemic activity of 2′deoxy-2′(S)-methylcytidine,” Chem. Pharm. Bull., 1987, 35, 3967-3970.Applicant
• Matsuda, A., et al., “Nucleosides and Nucleotides. 94. Radical deoxygenation of tert-alcohols in 1-(2-C-alkylpentofuranosyl)pyrimidines: Synthesis of (2′S)-2′-deoxy-2′-C-methylcytidine, an antileukemic nucleoside,” J. Med. Chem., 1991, 34, 234-239.Applicant
• Matsuda, A., et al, “Nucleosides and Nucleotides. 104. Radical and palladium-catalyzed deoxygenation of the allylic alcohol systems in the sugar moiety of pyrimidine nucleosides,” Nucleosides & Nucleotides, 1992, 11(No. 2/4), 197-226.Applicant
• Matsuda, A., et al., “Alkyl addition reaction of pyrimidine 2′-ketonucleosides: synthesis of 2′-branched-chain sugar pyrimidine nucleosides (Nucleosides and nucleotides. LXXXI.),” Chemical & Pharmaceutical Bulletin, Mar. 1988, 36, 945-953.Applicant
• Mikhailov, S.N., et al, “Synthesis and properties of 3′-C-methylnucleosides and their phosphoric esters,” Carbohydrate Research, 1983, 124, 75-96.Applicant
• Mikhailov, S.N., et al, “Hydrolysis of 2′- and 3′-C-methyluridine 2′,3′-cyclid monophosphates and interconversion and dephosphorylation of the resulting 2′- and 3′-monophosphates: comparison with the reactions of uridine monophosphates,” J. Org. Chem., 1992, 57, 4122-4126.Applicant
• Mikhailov, S.N., et al, “Substrate properties of C′-methylnucleoside and C′-methyl-2′-deoxynucleoside 5′-triphophates in RNA and DNA synthesis reactions catalysed by RNA and DNA polymerases,” Nucleosides & Nucleotides, 1991, 10, 339-343.Applicant
• Nutt, R.F., et al., “Branched-chain sugar nucleosides. III. 3′-C-methyladenine,” J. Org. Chem. 1968, 33, 1789-1795.Applicant
• Oivanen, M., et al, “Additional evidence for the exceptional mechanism of the acid-catalysed hydrolysis of 4-oxopyrimidine nucleosides: hydrolysis of 1-(1-alkoxyalkyl)uracils. Seconucleosides. 3′-C-alkyl nucleosides and nucleosides 3′,5′-cyclic monophosphates,” J. Chem. Soc. Perkin Trans., 1994, 2, 309-314.Applicant
• Ong, S.P., et al, “Synthesis of 3′-C-methyl adenosine and 3′-C-methyluridine diphosphates and their interaction with the ribonucleoside diphosphate reductase from Corynebacterium nephridii,” Biochemistry, 1992, 31, 11210-11215.Applicant
• Pan-Zhou X-R, et al., “Differential effects of antiretroviral nucleoside analogs on mitochondrial function in HepG2 cells,” Antimicrob Agents Chemother 2000; 44(No. 3), 496-503.Applicant
• Rosenthal, A., et al, “Branched-chain sugar nucleosides. Synthesis of 3′-C-ethyl (and 3′-C-butyl)uridine,” Carbohydrate Research, 1980, 79, 235-242.Applicant
• Samano, V., et al, “Nucleic acid related compounds. 77.2′,3′-didehydro-2′,3′-dideosy-2′(and 3′)-methylnucleosides via [3,3]-sigmatropic rearrangements of 2′(and 3′)-methylene-3′(and 2′)-O-thiocarbonyl derivatives and radical reducation of a 2′-chloro-3′-methylene analogue,”Can. J. Chem., 1993, 71, 186-191.Applicant
• Samano, V., et al, “Synthesis and radical-induced ring-opening reactions of 2′-deoxyadenosine-2′-spirocyclopropane and its uridine analogs. Mechanistic probes for ribonucleotide reductases,” J. Am. Chem. Soc., 1992, 114, 4007-4008.Applicant
• Schmidt, C. et al., “The effects of 2′-and 3′-alkyl substituents on oligonucleotide hybridization and stability,”, Biorganic & Medicinal Chemistry Letters, 1994, 4(No. 16), 1969-1974.Applicant
• Serafinowski, P.J., et al, “New method for the preparation of some 2′- and 3′-trifluoromethyl-2′-3′-dideoxyuridine derivatives,” Tetrahedron, 1999, 56(No. 2), 333-339.Applicant
• Sharma, P.K., et al, “Synthesis of 3′-trifluoromethyl nucleosides as potential antiviral agents,” Nucleosides, Nucleotides and Nucleic Acids, 2000, 19(No. 4), 757-774.Applicant
• Sommadossi J-P, et al., “Comparison of cytotoxicity of the (−)- and (+)-enantiomer of 2′,3′-dideoxy-3′-thiacytidine in normal human bone marrow progenitor cells,” Biochemical Pharmacology, 1992; 44:1921-1925.Applicant
• Sommadossi J-P, et al., “Toxicity of 3′-azido-3′-deoxythymidine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine for normal human hematopoietic progenitor cells in vitro,” Antimicrobial Agents and Chemotherapy, 1987, 31(No. 3), 452-454.Applicant
• Tritsch, D., et al., “3′-β-ethynyl and 2′-deoxy-3′-β-ethynyl adenosines: first 3′-β-branched-adenosines substrates of adenosine deaminase,” Bioorganic & Medicinal Chemistry Letters, 2000, 10, 139-141.Applicant
• Tunitskaya, V.L., et al, “Substrate properties of C′-methyl UTP derivatives in T7 RNA polymerase reactions. Evidence for N-type NTP conformation,” FEBS Letters, 1997, 400, 263-266.Applicant
• Usui, H., et al, “Synthesis of 2′-deoxy-8,2′-ethanoadenosine and 3′-deoxy-8,3′-ethanoadenosine (Nucleosides and Nucleotides. LXIV),” Chem. Pharm. Bull., 1986, 34, 15-23.Applicant
• Walczak, K., et al, “Synthesis of 1-(3-alkyl-2,3-dideoxy-D-pentofuranosyl)uracils with potential anti-HIV activity,” Acta Chemica Scand., 1991, 45, 930-934.Applicant
• Walton, E., et al, “Branched-chain sugar nucleosides. V. Synthesis and antiviral properties of several branched-chain sugar nucleosides,” J. Med. Chem., 1969, 12, 306-309.Applicant
• Wolfe, M.S., et al, “A concise synthesis of 2′-C-methylribonucleosides,” Tetrahedron Letters, 1995, 36(No. 42), 7611-7614.Applicant
• Wu, J.-C., et al, “A new stereospecific synthesis of [3.1.0] bicyclic cyclopropano analog of2′,3′-dideoxyuridine,” Tetrahedron, 1990, 46, 2587-2592.Applicant
• Jasko Maxim Vvan I Fedorov et al: “Synthesis, Molecular and Crystal Structure of 3′-N-Alkylamino-3′-Deoxythymidines and some Biochemical Properties of their Phosphorus Esters,” Nucleosides & Nucleotides, 1995, pp. 23-27, vol. 14, No. 1-2, XP008049088.Applicant
• Tsibinogin, V. V. et al: “Inhibition of the Replication of Human Hepatitis B Virus,” Database CA [Online], Chemical Abstracts Service, Columbus, Ohio, US; 1989, XP002192805.Applicant
• Matthes, Eckart et al: “Comparative Inhibition of Hepatitis B Virus DNA Polymerase and Cellular DNA Polymerases by Triphosphates of Sugar-Modified 5-Methyldeoxycytidines and of other Nucleoside Analogs,” Database CA [Online], Chemical Abstracts Service, Columbus, Ohio, US; 1991, XP002192806.Applicant
• Victorova Lyubov S et al: “Mode of Inhibition of HIV Reverse Transcriptase-Catalyzed DNA Synthesis by 3′-Amino-3′-Deoxythymidine 5′- Triphosphate,” Nucleosides & Nucleotides, 1996, pp. 655-667, vol. 15, No. 1-3, XP001062295.Applicant
• Ueda, Toru et al: “Preparation of 2′-Deoxy-2′ (S)-Alkylpyrimidine Nucleosides as Antiviral Agents,” Database CA [Online], Chemical Abstracts Service, Columbus, Ohio, US; 1988, XP002192807.Applicant
• Matsuda, Akira et al: “Preparation of 2′Deoxy-(2′ S)-Alkylpyrimidine Nucleosides as Antiviral Agents,” Database CA [Online], Chemical Abstracts Service, Columbus, Ohio, US; 1994, XP002192808.Applicant
• Matthes, E. et al: “Potent Inhibition of Hepatitis B Virus Production in Vitro by Modified Pyrimidine Nucleosides,” Database CA [Online], Chemical Abstracts Service, Columbus, Ohio, US; 1990, XP002192809.Applicant
• Kochetkova, S. V. et al: “Phosphorylation of 3′-Deoxy-3′-Aminothymidine in the Mouse Myeloma p38Ag653 Cell Culture and its Incorporation into DNA,” Database CA [Online], Chemical Abstracts Service, Columbus, Ohio, US; 1985, XP002333614.Applicant